Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Advaxia Biologics (formerly Advent), part of the IRBM Group, is a cGMP-compliant CDMO based in Pomezia, Italy, meeting EMA, MHRA, and FDA standards. We specialize in the development and GMP manufacturing of recombinant adenoviruses for vaccine and gene therapy clinical trials. Our integrated services include analytical and process development, QC release, stability studies, and cell banking. With proven expertise in infectious...
Advaxia Biologics (formerly Advent), part of the IRBM Group, is a cGMP-compliant CDMO based in Pomezia, Italy, meeting EMA, MHRA, and FDA standards. We specialize in the development and GMP manufacturing of recombinant adenoviruses for vaccine and gene therapy clinical trials. Our integrated services include analytical and process development, QC release, stability studies, and cell banking. With proven expertise in infectious diseases like Ebola, HIV, and COVID-19, Advaxia is a trusted partner in advancing global healthcare.

List your booth number for exhibitions, ask us